Diagnostic value of EBUS-TBNA for lung cancer with non-enlarged lymph nodes: A study in a Tuberculosis-Endemic Country

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Kuo, Chih Hsi ^a   Chen, Hao Cheng ^a   Chung, Fu Tsai ^a   Lo, Yu Lun ^a   Lee, Kang Yun ^a   Wang, Chih Wei ^b   Kuo, Wen Han ^b   Yen, Tzu Chen ^b   Kuo, Han Pin ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENDEMIC DISEASE; ENDOBRONCHIAL ULTRASONOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; LUNG HILUS LYMPH NODE; LUNG TUBERCULOSIS; LYMPH NODE; LYMPHATIC SYSTEM EXAMINATION; MALE; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; TRANSBRONCHIAL ASPIRATION; ADENOCARCINOMA; BRONCHOSCOPY; CANCER STAGING; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; EVALUATION; LUNG TUMOR; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; ORGAN SIZE; PATHOLOGY;

ADENOCARCINOMA; AGED; BIOPSY, FINE-NEEDLE; BRONCHOSCOPY; DIAGNOSIS, DIFFERENTIAL; ENDEMIC DISEASES; ENDOSONOGRAPHY; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY;

EID: 79952182941     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016877     Document Type: Article

References (33)

1. Doddoli C, Aragon A, Barlesi F, Chetaille B, Robitail S, et al. (2005) Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer? Eur J Cardiothorac Surg 27: 680-685.
2. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL, (2003) Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 21: 1029-1034.
3. Keller SM, Adak S, Wagner H, Johnson DH, (2000) Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg 70: 358-365; discussion 365-356.
4. Kramer H, Groen HJ, (2003) Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer. Ann Surg 238: 180-188.
5. Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, et al. (1997) Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET). Thorax 52: 438-441.
6. Gupta NC, Graeber GM, Bishop HA, (2000) Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. Chest 117: 773-778.
7. Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verschakelen JA, et al. (1997) Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group. Chest 112: 1480-1486.
8. Bakheet SM, Powe J, (1998) Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 28: 352-358.
9. Roberts PF, Follette DM, von Haag D, Park JA, Valk PE, et al. (2000) Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 70: 1154-1159; discussion 1159-1160.
10. Kim YK, Lee KS, Kim BT, Choi JY, Kim H, et al. (2007) Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer 109: 1068-1077.
11. Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, et al. (2007) The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Clin Nucl Med 32: 607-612.
12. Konishi J, Yamazaki K, Tsukamoto E, Tamaki N, Onodera Y, et al. (2003) Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 70: 500-506.
13. Yasufuku K, Chiyo M, Sekine Y, Chhajed PN, Shibuya K, et al. (2004) Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest 126: 122-128.
14. Yasufuku K, Chiyo M, Koh E, Moriya Y, Iyoda A, et al. (2005) Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer 50: 347-354.
15. Herth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A, (2006) Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax 61: 795-798.
16. Herth FJ, Annema JT, Eberhardt R, Yasufuku K, Ernst A, et al. (2008) Endobronchial ultrasound with transbronchial needle aspiration for restaging the mediastinum in lung cancer. J Clin Oncol 26: 3346-3350.
17. Herth FJ, Eberhardt R, Krasnik M, Ernst A, (2008) Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest 133: 887-891.
18. Herth FJ, Ernst A, Eberhardt R, Vilmann P, Dienemann H, et al. (2006) Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum. Eur Respir J 28: 910-914.
19. Cerfolio RJ, Bryant AS, Eloubeidi MA, Frederick PA, Minnich DJ, et al. The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer. Ann Thorac Surg 90: 427-434.
20. Lee HS, Lee GK, Lee HS, Kim MS, Lee JM, et al. (2008) Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest 134: 368-374.
21. Wallace MB, Pascual JM, Raimondo M, Woodward TA, McComb BL, et al. (2008) Minimally invasive endoscopic staging of suspected lung cancer. Jama 299: 540-546.
22. Takamochi K, Nagai K, Yoshida J, Suzuki K, Ohde Y, et al. (2000) The role of computed tomographic scanning in diagnosing mediastinal node involvement in non-small cell lung cancer. J Thorac Cardiovasc Surg 119: 1135-1140.
23. Castell F, Cook GJ, (2008) Quantitative techniques in 18FDG PET scanning in oncology. Br J Cancer 98: 1597-1601.
24. Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, et al. (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343: 254-261.
25. Schrevens L, Lorent N, Dooms C, Vansteenkiste J, (2004) The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist 9: 633-643.
26. Takamochi K, Yoshida J, Murakami K, Niho S, Ishii G, et al. (2005) Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer 47: 235-242.
27. Gawne-Cain ML, Hansell DM, (1996) The pattern and distribution of calcified mediastinal lymph nodes in sarcoidosis and tuberculosis: a CT study. Clin Radiol 51: 263-267.
28. Bowerman RJ, (2004) Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan. Int J Tuberc Lung Dis 8: 1228-1233.
29. Yeh YP, Luh DL, Chang SH, Suo J, Chang HJ, et al. (2005) Tuberculin reactivity in adults after 50 years of universal bacille Calmette-Guerin vaccination in Taiwan. Trans R Soc Trop Med Hyg 99: 509-516.
30. Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, et al. (2001) Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med 28: 696-703.
31. Matthies A, Hickeson M, Cuchiara A, Alavi A, (2002) Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 43: 871-875.
32. Nishiyama Y, Yamamoto Y, Kimura N, Ishikawa S, Sasakawa Y, et al. (2008) Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer. Ann Nucl Med 22: 245-250.
33. Yen RF, Chen KC, Lee JM, Chang YC, Wang J, et al. (2008) 18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort? Eur J Nucl Med Mol Imaging 35: 1305-1315.